{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:47Z","timestamp":1772166347002,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730028"],"award-info":[{"award-number":["81730028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800899"],"award-info":[{"award-number":["81800899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC2020CR1044B"],"award-info":[{"award-number":["SHDC2020CR1044B"]}]},{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["SHIPM-mu fund from Shanghai Institute of Precision Medicine"],"award-info":[{"award-number":["SHIPM-mu fund from Shanghai Institute of Precision Medicine"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["Ninth People\u2019s Hospital-JC201802"],"award-info":[{"award-number":["Ninth People\u2019s Hospital-JC201802"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["Youth Medical Talents \u2013 Specialist Program"],"award-info":[{"award-number":["Youth Medical Talents \u2013 Specialist Program"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["21YF1424200"],"award-info":[{"award-number":["21YF1424200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>POU3F4<\/jats:italic>\n                      is the causative gene for X-linked deafness-2 (DFNX2), characterized by incomplete partition type III (IP-III) malformation of the inner ear. The purpose of this study was to investigate the clinical characteristics and molecular findings in IP-III patients by Sanger or nanopore single-molecule sequencing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Diagnosis of IP-III was mainly based on clinical characteristics including radiological and audiological findings. Sanger sequencing of\n                      <jats:italic>POU3F4<\/jats:italic>\n                      was carried out for these IP-III patients. For those patients with negative results for\n                      <jats:italic>POU3F4<\/jats:italic>\n                      Sanger sequencing, nanopore long-read single-molecule sequencing was used to identify the possible pathogenic variants. Hearing intervention outcomes of hearing aids (HAs) fitting and cochlear implantation (CI) were also analyzed. Aided pure tone average (PTA) was further compared between two groups of patients according to their different locations of\n                      <jats:italic>POU3F4<\/jats:italic>\n                      variants: in the exon region or in the upstream region.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 18 male patients from 14 unrelated families were diagnosed with IP-III. 10 variants were identified in\n                      <jats:italic>POU3F4<\/jats:italic>\n                      by Sanger sequencing and 6 of these were reported for the first time (p.Gln181*, p.Val215Gly, p.Arg282Gln, p.Gln316*, c.903_912 delins TGCCA and p.Arg205del). Four different deletions that varied from 80 to 486\u00a0kb were identified 876\u20131503\u00a0kb upstream of\n                      <jats:italic>POU3F4<\/jats:italic>\n                      by nanopore long-read single-molecule sequencing. De novo genetic mutations occurred in 21.4% (3\/14) of patients with\n                      <jats:italic>POU3F4<\/jats:italic>\n                      mutations. Among these 18 patients, 7 had bilateral HAs and 10 patients received unilateral CI. The mean aided PTA for HAs and CI users were 41.1\u2009\u00b1\u20095.18 and 40.3\u2009\u00b1\u20097.59\u00a0dB HL respectively. The mean PTAs for patients with the variants located in the exon and upstream regions were 39.6\u2009\u00b1\u20096.31 versus 43.0\u2009\u00b1\u20097.10\u00a0dB HL, which presented no significant difference (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.342).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Among 14 unrelated IP-III patients, 28.6% (4\/14) had no definite mutation in exon region of\n                      <jats:italic>POU3F4<\/jats:italic>\n                      . However, possible pathogenic deletions were identified in upstream region of this gene\n                      <jats:italic>.<\/jats:italic>\n                      De novo genetic mutations occurred in 21.4% (3\/14) of patients with\n                      <jats:italic>POU3F4<\/jats:italic>\n                      mutation. There was no significant difference of hearing intervention outcomes between the IP-III patients with variants located in the exon region and in the upstream region.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-022-02235-7","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T13:10:51Z","timestamp":1645449051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic findings of Sanger and nanopore single-molecule sequencing in patients with X-linked hearing loss and incomplete partition type III"],"prefix":"10.1186","volume":"17","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengda","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Bin","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingxiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5317-902X","authenticated-orcid":false,"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"issue":"7","key":"2235_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3109\/00016489.2011.554440","volume":"131","author":"E Berninger","year":"2011","unstructured":"Berninger E, Westling B. Outcome of a universal newborn hearing-screening programme based on multiple transient-evoked otoacoustic emissions and clinical brainstem response audiometry. Acta Oto-laryngol. 2011;131(7):728\u201339.","journal-title":"Acta Oto-laryngol"},{"key":"2235_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.1991.tb19572.x","volume":"630","author":"NE Morton","year":"1991","unstructured":"Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci. 1991;630:16\u201331.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2235_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ajmg.1320460504","volume":"46","author":"ML Marazita","year":"1993","unstructured":"Marazita ML, Ploughman LM, Rawlings B, Remington E, Arnos KS, Nance WE. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet. 1993;46(5):486\u201391.","journal-title":"Am J Med Genet"},{"issue":"5198","key":"2235_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1126\/science.7839145","volume":"267","author":"YJ de Kok","year":"1995","unstructured":"de Kok YJ, van der Maarel SM, Bitner-Glindzicz M, Huber I, Monaco AP, Malcolm S, Pembrey ME, Ropers HH, Cremers FP. Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science. 1995;267(5198):685\u20138.","journal-title":"Science"},{"issue":"7","key":"2235_CR5","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/j.1460-2075.1992.tb05320.x","volume":"11","author":"JM Mathis","year":"1992","unstructured":"Mathis JM, Simmons DM, He X, Swanson LW, Rosenfeld MG. Brain 4: a novel mammalian POU domain transcription factor exhibiting restricted brain-specific expression. EMBO J. 1992;11(7):2551\u201361.","journal-title":"EMBO J"},{"key":"2235_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12881-015-0149-2","volume":"16","author":"G Bademci","year":"2015","unstructured":"Bademci G, Lasisi A, Yariz KO, Montenegro P, Menendez I, Vinueza R, Paredes R, Moreta G, Subasioglu A, Blanton S, et al. Novel domain-specific POU3F4 mutations are associated with X-linked deafness: examples from different populations. BMC Med Genet. 2015;16:9.","journal-title":"BMC Med Genet"},{"issue":"8","key":"2235_CR7","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1073\/pnas.89.8.3285","volume":"89","author":"C Le Moine","year":"1992","unstructured":"Le Moine C, Young WS 3rd. RHS2, a POU domain-containing gene, and its expression in developing and adult rat. Proc Natl Acad Sci USA. 1992;89(8):3285\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2235_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/(SICI)1520-6408(1996)19:2<108::AID-DVG2>3.0.CO;2-D","volume":"19","author":"JA Dominov","year":"1996","unstructured":"Dominov JA, Miller JB. POU homeodomain genes and myogenesis. Dev Genet. 1996;19(2):108\u201318.","journal-title":"Dev Genet"},{"issue":"12","key":"2235_CR9","doi-asserted-by":"publisher","first-page":"7186","DOI":"10.1128\/MCB.17.12.7186","volume":"17","author":"MA Hussain","year":"1997","unstructured":"Hussain MA, Lee J, Miller CP, Habener JF. POU domain transcription factor brain 4 confers pancreatic alpha-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element. Mol Cell Biol. 1997;17(12):7186\u201394.","journal-title":"Mol Cell Biol"},{"issue":"1\u20132","key":"2235_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0378-5955(98)00059-8","volume":"120","author":"D Phippard","year":"1998","unstructured":"Phippard D, Heydemann A, Lechner M, Lu L, Lee D, Kyin T, Crenshaw EB 3rd. Changes in the subcellular localization of the Brn4 gene product precede mesenchymal remodeling of the otic capsule. Hear Res. 1998;120(1\u20132):77\u201385.","journal-title":"Hear Res"},{"issue":"14","key":"2235_CR11","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.1523\/JNEUROSCI.19-14-05980.1999","volume":"19","author":"D Phippard","year":"1999","unstructured":"Phippard D, Lu L, Lee D, Saunders JC, Crenshaw EB 3rd. Targeted mutagenesis of the POU-domain gene Brn4\/Pou3f4 causes developmental defects in the inner ear. J Neurosci Off J Soc Neurosci. 1999;19(14):5980\u20139.","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"9","key":"2235_CR12","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/archotol.126.9.1065","volume":"126","author":"B Arellano","year":"2000","unstructured":"Arellano B, Ramirez Camacho R, Garcia Berrocal JR, Villamar M, del Castillo I, Moreno F. Sensorineural hearing loss and Mondini dysplasia caused by a deletion at locus DFN3. Arch Otolaryngol Head Neck Surg. 2000;126(9):1065\u20139.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"2235_CR13","first-page":"64","volume":"07","author":"WE Nance","year":"1971","unstructured":"Nance WE, Setleff R, McLeod A, Sweeney A, Cooper C, McConnell F. X-linked mixed deafness with congenital fixation of the stapedial footplate and perilymphatic gusher. Birth Defects Orig Artic Ser. 1971;07(4):64\u20139.","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"12","key":"2235_CR14","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1097\/00005537-200212000-00019","volume":"112","author":"L Sennaroglu","year":"2002","unstructured":"Sennaroglu L, Saatci I. A new classification for cochleovestibular malformations. Laryngoscope. 2002;112(12):2230\u201341.","journal-title":"Laryngoscope"},{"issue":"8","key":"2235_CR15","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/hmg\/4.8.1467","volume":"4","author":"M Bitner-Glindzicz","year":"1995","unstructured":"Bitner-Glindzicz M, Turnpenny P, Hoglund P, Kaariainen H, Sankila EM, van der Maarel SM, de Kok YJ, Ropers HH, Cremers FP, Pembrey M, et al. Further mutations in Brain 4 (POU3F4) clarify the phenotype in the X-linked deafness, DFN3. Hum Mol Genet. 1995;4(8):1467\u20139.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2235_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1152\/physiolgenomics.00100.2009","volume":"39","author":"HK Lee","year":"2009","unstructured":"Lee HK, Song MH, Kang M, Lee JT, Kong KA, Choi SJ, Lee KY, Venselaar H, Vriend G, Lee WS, et al. Clinical and molecular characterizations of novel POU3F4 mutations reveal that DFN3 is due to null function of POU3F4 protein. Physiol Genom. 2009;39(3):195\u2013201.","journal-title":"Physiol Genom"},{"issue":"9","key":"2235_CR17","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1073\/pnas.0813178106","volume":"106","author":"R Datta","year":"2009","unstructured":"Datta R, Waheed A, Bonapace G, Shah GN, Sly WS. Pathogenesis of retinitis pigmentosa associated with apoptosis-inducing mutations in carbonic anhydrase IV. Proc Natl Acad Sci USA. 2009;106(9):3437\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2235_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/humu.22232","volume":"34","author":"BY Choi","year":"2013","unstructured":"Choi BY, Kim DH, Chung T, Chang M, Kim EH, Kim AR, Seok J, Chang SO, Bok J, Kim D, et al. Destabilization and mislocalization of POU3F4 by C-terminal frameshift truncation and extension mutation. Hum Mutat. 2013;34(2):309\u201316.","journal-title":"Hum Mutat"},{"issue":"5","key":"2235_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4274\/balkanmedj.2017.0367","volume":"34","author":"L Sennaroglu","year":"2017","unstructured":"Sennaroglu L, Bajin MD. Classification and current management of inner ear malformations. Balkan Med J. 2017;34(5):397\u2013411.","journal-title":"Balkan Med J"},{"issue":"1","key":"2235_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.anl.2017.02.006","volume":"45","author":"L Sennaroglu","year":"2018","unstructured":"Sennaroglu L, Bajin MD. Incomplete partition type III: a rare and difficult cochlear implant surgical indication. Auris Nasus Larynx. 2018;45(1):26\u201332.","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"2235_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/MAO.0000000000001253","volume":"38","author":"H Smeds","year":"2017","unstructured":"Smeds H, Wales J, Asp F, Lofkvist U, Falahat B, Anderlid BM, Anmyr L, Karltorp E. X-linked malformation and cochlear implantation. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol. 2017;38(1):38\u201346.","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"issue":"6","key":"2235_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/cge.12110","volume":"75","author":"HK Lee","year":"2009","unstructured":"Lee HK, Lee SH, Lee KY, Lim EJ, Choi SY, Park RK, Kim UK. Novel POU3F4 mutations and clinical features of DFN3 patients with cochlear implants. Clin Genet. 2009;75(6):572\u20135.","journal-title":"Clin Genet"},{"issue":"12","key":"2235_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1177\/000348941011901205","volume":"119","author":"KM Stankovic","year":"2010","unstructured":"Stankovic KM, Hennessey AM, Herrmann B, Mankarious LA. Cochlear implantation in children with congenital X-linked deafness due to novel mutations in POU3F4 gene. Ann Otol Rhinol Laryngol. 2010;119(12):815\u201322.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"6","key":"2235_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20203740","volume":"41","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Wu L, Huang S, Li P, Gao B, Yuan Y, Zhang S, Yu G, Gao Y, Wu H, et al. Study of complex structural variations of X-linked deafness-2 based on single-molecule sequencing. Biosci Rep. 2021;41(6):1\u20139.","journal-title":"Biosci Rep"},{"issue":"9","key":"2235_CR25","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/hmg\/5.9.1229","volume":"5","author":"YJ de Kok","year":"1996","unstructured":"de Kok YJ, Vossenaar ER, Cremers CW, Dahl N, Laporte J, Hu LJ, Lacombe D, Fischel-Ghodsian N, Friedman RA, Parnes LS, et al. Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum Mol Genet. 1996;5(9):1229\u201335.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2235_CR26","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s00405-013-2386-3","volume":"270","author":"BY Choi","year":"2013","unstructured":"Choi BY, An YH, Park JH, Jang JH, Chung HC, Kim AR, Lee JH, Kim CS, Oh SH, Chang SO. Audiological and surgical evidence for the presence of a third window effect for the conductive hearing loss in DFNX2 deafness irrespective of types of mutations. Eur Arch Oto-rhino-laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc. 2013;270(12):3057\u201362.","journal-title":"Eur Arch Oto-rhino-laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc"},{"issue":"12","key":"2235_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/archotol.131.12.1057","volume":"131","author":"AP Vore","year":"2005","unstructured":"Vore AP, Chang EH, Hoppe JE, Butler MG, Forrester S, Schneider MC, Smith LL, Burke DW, Campbell CA, Smith RJ. Deletion of and novel missense mutation in POU3F4 in 2 families segregating X-linked nonsyndromic deafness. Arch Otolaryngol Head Neck Surg. 2005;131(12):1057\u201363.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"2235_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MAO.0000000000000343","volume":"36","author":"JW Choi","year":"2015","unstructured":"Choi JW, Min B, Kim A, Koo JW, Kim CS, Park WY, Chung J, Kim V, Ryu YJ, Kim SH, et al. De novo large genomic deletions involving POU3F4 in incomplete partition type III inner ear anomaly in East Asian populations and implications for genetic counseling. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol. 2015;36(1):184\u201390.","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"issue":"1","key":"2235_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1044\/1059-0889(2013\/13-0018)","volume":"23","author":"GJ Anger","year":"2014","unstructured":"Anger GJ, Crocker S, McKenzie K, Brown KK, Morton CC, Harrison K, MacKenzie JJ. X-linked deafness-2 (DFNX2) phenotype associated with a paracentric inversion upstream of POU3F4. Am J Audiol. 2014;23(1):1\u20136.","journal-title":"Am J Audiol"},{"issue":"10","key":"2235_CR30","doi-asserted-by":"publisher","first-page":"e0205298","DOI":"10.1371\/journal.pone.0205298","volume":"13","author":"C Aristidou","year":"2018","unstructured":"Aristidou C, Theodosiou A, Bak M, Mehrjouy MM, Constantinou E, Alexandrou A, Papaevripidou I, Christophidou-Anastasiadou V, Skordis N, Kitsiou-Tzeli S, et al. Position effect, cryptic complexity, and direct gene disruption as disease mechanisms in de novo apparently balanced translocation cases. PLoS ONE. 2018;13(10):e0205298.","journal-title":"PLoS ONE"},{"key":"2235_CR31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3389\/fphar.2018.00861","volume":"9","author":"Z Xiang","year":"2018","unstructured":"Xiang Z, Huang X, Wang J, Zhang J, Ji J, Yan R, Zhu Z, Cai W, Yu Y. Cross-database analysis reveals sensitive biomarkers for combined therapy for ERBB2+ gastric cancer. Front Pharmacol. 2018;9:861.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2235_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-020-01577-z","volume":"39","author":"H Li","year":"2020","unstructured":"Li H, Zhang M, Wei Y, Haider F, Lin Y, Guan W, Liu Y, Zhang S, Yuan R, Yang X, et al. SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane. J Exp Clin Cancer Res CR. 2020;39(1):81.","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"4","key":"2235_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1080\/10428194.2017.1344843","volume":"59","author":"L Xu","year":"2018","unstructured":"Xu L, Zhang M, Li H, Guan W, Liu B, Liu F, Wang H, Li J, Yang S, Tong X, et al. SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia. Leukemia Lymphoma. 2018;59(4):918\u201330.","journal-title":"Leukemia Lymphoma"},{"issue":"3","key":"2235_CR34","doi-asserted-by":"publisher","first-page":"E123","DOI":"10.1002\/lary.25573","volume":"126","author":"BY Choi","year":"2016","unstructured":"Choi BY, An YH, Song JJ, Koo JW, Lee JH, Oh SH, Chang SO, Kim CS, Park JH. Clinical observations and molecular variables of patients with hearing loss and incomplete partition type III. Laryngoscope. 2016;126(3):E123\u20138.","journal-title":"Laryngoscope"},{"issue":"2","key":"2235_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/0003489415604167","volume":"125","author":"L Kim","year":"2016","unstructured":"Kim L, Wisely CE, Lucius S, Weingarten J, Dodson EE. Positive outcomes and surgical strategies for bilateral cochlear implantation in a child with X-linked deafness. Ann Otol Rhinol Laryngol. 2016;125(2):173\u20136.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"2235_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuron.2011.10.029","volume":"73","author":"TM Coate","year":"2012","unstructured":"Coate TM, Raft S, Zhao X, Ryan AK, Crenshaw EB 3rd, Kelley MW. Otic mesenchyme cells regulate spiral ganglion axon fasciculation through a Pou3f4\/EphA4 signaling pathway. Neuron. 2012;73(1):49\u201363.","journal-title":"Neuron"},{"issue":"2","key":"2235_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/AUD.0000000000000467","volume":"39","author":"S He","year":"2018","unstructured":"He S, Shahsavarani BS, McFayden TC, Wang H, Gill KE, Xu L, Chao X, Luo J, Wang R, He N. Responsiveness of the electrically stimulated cochlear nerve in children with cochlear nerve deficiency. Ear Hear. 2018;39(2):238\u201350.","journal-title":"Ear Hear"},{"issue":"Pt A","key":"2235_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.heares.2015.07.010","volume":"330","author":"BE Pfingst","year":"2015","unstructured":"Pfingst BE, Hughes AP, Colesa DJ, Watts MM, Strahl SB, Raphael Y. Insertion trauma and recovery of function after cochlear implantation: evidence from objective functional measures. Hear Res. 2015;330(Pt A):98\u2013105.","journal-title":"Hear Res"},{"issue":"12","key":"2235_CR39","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/cne.24867","volume":"528","author":"PM Brooks","year":"2020","unstructured":"Brooks PM, Rose KP, MacRae ML, Rangoussis KM, Gurjar M, Hertzano R, Coate TM. Pou3f4-expressing otic mesenchyme cells promote spiral ganglion neuron survival in the postnatal mouse cochlea. J Comp Neurol. 2020;528(12):1967\u201385.","journal-title":"J Comp Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02235-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02235-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02235-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T13:28:59Z","timestamp":1645450139000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02235-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2235"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02235-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-501574\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"6 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants gave written, informed consent to participate in this study. The study was approved by the Ethics Committee of the Ninth People\u2019s Hospital, Shanghai Jiaotong University School of Medicine (No. SH9H-2019-T245-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A consent for publication has been obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}